Auro Laboratories’ record shows seven years of unqualified audit opinions and a promoter group that holds its stake without pledging a single share. The real question is whether the reported asset values match the business reality: revenue has shrunk 64% while customer collections have slowed to 179 days, yet the company has booked no provision for credit losses.
Key findings
- Revenue fell 64% and receivables days nearly doubled, but no credit-loss provision was made
Major- Revenue from operations dropped to ₹19.4 crore in FY25 from ₹53.64 crore in FY24. Trade receivables days stretched to 179 days from 93 days a year earlier, a slowdown the company attributes to delayed export receipts. Despite this, no allowance for expected credit losses was recognised on trade receivables under the simplified ECL approach. - Three auditors in four years, with two resigning mid-tenure without giving substantive reasons
Major- M/s. Khurdia Jain & Co. resigned effective 31 July 2023, citing inability to continue and raising no concerns. M/s. Kothari Jain & Associates, appointed for a five-year term in September 2023, resigned effective 23 August 2025 with a letter that marked all reason fields as “-” and stated “no other material reason other than those provided above”. Audit fees rose from ₹1 lakh in FY2022-23 to ₹4.85 lakhs in FY2025-26, with the FY2025-26 AGM notice proposing ₹6 lakhs. - Audit opinions are clean across seven years, but an audit trail gap and a going-concern reference in announcements sit outside the filed report
Minor- The statutory audit opinion was unqualified every year from FY2019-20 through FY2025-26. The FY2023-24 auditor’s report states the company did not implement the audit trail (edit log) required in accounting software from 1 April 2023. Four announcements in May and June 2024 said the auditor’s report for the year ended 31 March 2024 “includes a material uncertainty related to going concern,” but the filed auditor’s report contains no such paragraph and the CARO clause xix explicitly states no material uncertainty exists. - A ₹1.92 crore environmental compensation demand is stayed by the Supreme Court, and a new GST demand of ₹42.43 lakhs has been contested
Minor- The Maharashtra Pollution Control Board and Tarapur Environment Protection Society demanded ₹1.92 crore for environmental damage; the company deposited 30% (₹57.59 lakhs) under protest and obtained a stay from the Supreme Court. A GST demand of ₹42.43 lakhs for FY2019-20 was received, and the company filed an appeal with a pre-deposit of ₹2.19 lakhs, making no provision based on management’s assessment. - Promoter family holds board control, with small dissent on Chairman’s re-appointment
Minor- Promoter shareholding stands at 52.41% with zero pledge. Mr. Sharat Deorah (Chairman & Managing Director) and his son Mr. Siddhartha Deorah (Whole-Time Director) are the only directors with a family relationship, disclosed consistently from FY2020-21 through FY2025-26. At the 35th AGM on 28 June 2024, the special resolution to re-appoint Mr. Sharat Deorah for three years and continue his term beyond age 70 drew 6,016 votes against (0.18% of votes cast) from public non-institutional shareholders. - KMP appointments have been repeatedly delayed under SEBI Listing Regulations, with no monetary penalties reported
Minor- The Secretarial Audit Report for FY2025-26 records a qualification for delay in appointing a CFO within the timeline prescribed by Regulation 26A(2); the CFO was appointed on 30 May 2025. The FY2024-25 Corporate Governance report disclosed delays in appointing both a CFO and a Company Secretary & Compliance Officer for certain periods during that year. The company has stated in every annual report from FY2019-20 through FY2025-26 that no significant or material orders were passed by regulators or courts impacting its going concern status.
What to watch
- 37th AGM on 12 August 2026. Shareholders vote on the re-appointment of Mr. Kiran Suresh Kulkarni as Whole-Time Director for three years from 24 May 2027.
- FY2026-27 statutory audit. Completion and filing by M/s. B.L. Dasharda & Associates, whose appointment runs through the 41st AGM (FY2029-30).
- Tablet formulation capex. Commercial ramp-up and whether the proposed supply arrangement with a European customer materialises, as noted by Acuité on 14 April 2026.
- Environmental compensation appeal. Outcome of the Supreme Court appeal against the ₹1.92 crore MPCB/TEPS demand, no scheduled hearing date disclosed in the FY2025-26 Annual Report.
- GST appeal. Outcome before the Appellate Authority for the ₹42.43 lakhs demand for FY2019-20, no scheduled hearing date disclosed in the FY2025-26 Annual Report.
Bottom line: This is a promoter-controlled company with a clean audit trail on paper and zero pledged shares. The record is shaped by two forces pulling in opposite directions: a completed capacity expansion that could lift revenue from its FY25 trough, and a receivables book that has stretched to 179 days without any provision for the risk that some of those dues may not arrive. Watch whether the new auditor stays the course, and whether the tablet orders turn into cash.